---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-084846"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2026-08-04T01:12:26+00:00"
generated_at: "2026-08-04T10:05:33.798184+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma postpones BioKey share distribution from August 3, 2026

## Summary
- Distribution of BioKey ordinary shares postponed to complete administrative, regulatory, and tax-related matters.
- Record date and distribution ratio of 0.169464 BioKey shares per ABVC share remain unchanged.
- Ex-dividend date will be revised; new distribution date to be announced after matters are finalized.
- Company coordinating with Nasdaq, DTC, and transfer agent on revised distribution mechanics.

## SEC filing metadata
- accession: 0001213900-26-084846
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2026-08-04T01:12:26+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390026084846/0001213900-26-084846-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390026084846/ea0300449-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-084846
- JSON: https://secwatch.observer/filing/0001213900-26-084846.json
- Plain text: https://secwatch.observer/filing/0001213900-26-084846.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.